DEPLOYDatabase

Company

Rex Bionics

Rex Bionics develops the REX robotic exoskeleton, a hands-free, self-supporting mobility device that enables wheelchair users with spinal cord injury and other…

Founded
2003
HQ
Auckland, New Zealand
Status
private

The verified answer

As of Aug 2026, DEPLOY verifies Rex Bionics: 1 model, 4 deployments across 2 regions, $17.0M raised, 1 active incident. 4 sources back the record.

CategoryExoskeletons

Overview

Rex Bionics develops the REX robotic exoskeleton, a hands-free, self-supporting mobility device that enables wheelchair users with spinal cord injury and other neurological conditions to stand, walk, and exercise. Founded in Auckland in 2003, the company pioneered Robot-Assisted Physiotherapy (RAP) and ran the RAPPER II clinical trial across leading neuro-rehabilitation clinics in the UK and Australia. Rex Bionics was admitted to trading on the London Stock Exchange's AIM in 2014 under the ticker RXB.

Verified record

Verified deployments
4 deployments on file
Active incidents
1 incident on file

Valuation of record

Company-claimed
$170M (reported, approximate)as of Jul 2014

Priced roundIPO post-money

See the full valuations ranking →

Key facts

CEO

Crispin Simon (as of 2016)

CFO

Peter Worrall (as of 2016)

Tickersee public companies

AIM:RXB (admitted 2014)

FDA status

REX not registered for at-home use in the US (as of 2016)

Distribution

EnableMe (US), MAAB (China), Deltason (HK/Taiwan)

Data & sources

Web sources

4

4 sources backing this record.View all →

Partnerships

Every company Rex Bionics has built with, alongside the ones only announced in a press release.

3 total2 operating1 just announced

Most-frequent partners

  1. 1Deltason Medical1× joint
  2. 2EnableMe1× joint
  3. 3US Army1× joint

Most recent

  1. with US Armyjust announced
  2. with EnableMeoperating
  3. with Deltason Medicaloperating

Relationships

EEnableMeDistributorDDeltason MedicalDistributorUUS ArmyCo-developerPPublic marketsInvestorRRex BionicsCustomer

Current leadership (2)

Founders (2)

See all founders across the registry →

Former / Previously (2)

Safety record

1 incident on record (1 serious). Most recent: May 2016.

serious
1

Most recent: May 2016

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Incidents affecting Rex Bionics (1)

Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Operator customers (1)

Recent coverage

Rex Bionics in third-party press

Peers

26 peers across 1 segment. Every Rex Bionics competitor derived from shared form-factor and application-domain edges.

exoskeleton(26)

23 companies in this segment · highly_concentrated (HHI 5009.45179584121) · leader Hypershell at 5217%